Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety
- Anadolu Univ., Eskisehir (Turkey). Dept. of Pharmaceutical Chemistry. Faculty of Pharmacy
- Kumamoto Univ. (Japan). Dept. of Bioorganic Medicinal Chemistry. School of Pharmacy; SLAC National Accelerator Lab., Menlo Park, CA (United States). Stanford PULSE Inst.
- Kumamoto Univ. (Japan). Dept. of Bioorganic Medicinal Chemistry. School of Pharmacy; National Research Center, Cairo (Egypt). Dept. of Chemistry of Natural Compounds
- Kumamoto Univ. (Japan). Dept. of Bioorganic Medicinal Chemistry. School of Pharmacy; Minia Univ. (Egypt). Dept. of Medicinal Chemistry
- Kumamoto Univ. (Japan). Dept. of Bioorganic Medicinal Chemistry. School of Pharmacy
- Kumamoto Univ. (Japan). Research Inst. for Drug Discovery. School of Pharmacy
In an attempt to develop potent antitumor agents, new 1,3,4-thiadiazole derivatives were synthesized and evaluated for their cytotoxic effects on multiple human cancer cell lines, including the K562 chronic myelogenous leukemia cell line that expresses the Bcr-Abl tyrosine kinase. N-(5-Nitrothiazol-2-yl)-2-((5-((4-(trifluoromethyl)phenyl)amino)-1,3,4-thiadiazol-2-yl)thio)acetamide (2) inhibited the Abl protein kinase with an IC50 value of 7.4 µM and showed selective activity against the Bcr-Abl positive K562 cell line. Furthermore, a Bcr-Abl-compound 2 molecular modelling simulation highlighted the anchoring role of the nitrothiazole moiety in bonding and hydrophobic interaction with the key amino acid residues. These results provide promising starting points for further development of novel kinase inhibitors.
- Research Organization:
- Anadolu Univ., Eskisehir (Turkey); Kumamoto Univ. (Japan); SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- Anadolu Univ. Scientific Research Projects Commission (Turkey); Japanese Society for the Promotion of Science (JSPS); USDOE
- Grant/Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1425396
- Journal Information:
- Molecules, Journal Name: Molecules Journal Issue: 1 Vol. 23; ISSN 1420-3049
- Publisher:
- MDPICopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Synthesis and biological evaluation of novel disulfides incorporating 1,3,4-thiadiazole scaffold as promising antitumor agents
Nucleophilic reactions at a Vinylic Center. XVII. formation of derivatives of 1,3,4-thiadiazole and 1,3,4-oxadiazole in the reaction of 2,2-dichlorovinyl Sulfones with thiosemicarbazide and Semicarbazide
X-ray and Theoretical Studies of 2-((5-Amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone
Journal Article
·
Sun Sep 01 00:00:00 EDT 2019
· Medicinal Chemistry Research (Print)
·
OSTI ID:22936174
Nucleophilic reactions at a Vinylic Center. XVII. formation of derivatives of 1,3,4-thiadiazole and 1,3,4-oxadiazole in the reaction of 2,2-dichlorovinyl Sulfones with thiosemicarbazide and Semicarbazide
Journal Article
·
Fri Aug 01 00:00:00 EDT 1986
· J. Org. Chem. USSR (Engl. Transl.); (United States)
·
OSTI ID:6952844
X-ray and Theoretical Studies of 2-((5-Amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone
Journal Article
·
Thu Dec 14 23:00:00 EST 2017
· Crystallography Reports
·
OSTI ID:22758302